CBUI:XETRA:XETRA-iShares MSCI World Value Factor ESG UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 5.36

Change

+0.01 (+0.24)%

Market Cap

USD 0.26B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.16 (+0.32%)

USD 509.68B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.36%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.12 (+0.45%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.10 (+0.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.12 (+0.51%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.70 (+0.49%)

USD 100.74B
JARI:XETRA Amundi Index Solutions - Amund..

-0.02 (-0.05%)

USD 100.71B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.18 (+0.35%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.64 (+0.30%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.08 (+0.35%)

USD 79.79B

ETFs Containing CBUI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.63% 60% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.63% 60% D- 60% D-
Trailing 12 Months  
Capital Gain 15.47% 73% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.47% 72% C 72% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.90% 52% F 51% F
Dividend Return 4.90% 51% F 49% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.27% 72% C 78% C+
Risk Adjusted Return 67.40% 76% C+ 78% C+
Market Capitalization 0.26B 53% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike